DAVID KAVTARADZE: Open Payments
NPI 1376516484 · CORDELE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$854 in 47 payments from 14 companies in 2025. Trend: 2023 $1,826 · 2024 $1,423 · 2025 $854
Food & beverage: $854
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $323 |
| Lilly USA, LLC | 6 | $121 |
| GlaxoSmithKline, LLC. | 4 | $73 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $66 |
| Sumitomo Pharma America, Inc. | 3 | $61 |
| PFIZER INC. | 3 | $56 |
| Antares Pharma, Inc. | 2 | $42 |
| ABBVIE INC. | 1 | $21 |
| Novo Nordisk Inc | 1 | $18 |
| Exact Sciences Corporation | 1 | $17 |
Products named: FARXIGA, AIRSUPRA, MOUNJARO, TRELEGY ELLIPTA, Kerendia, GEMTESA, BREZTRI, ELIQUIS.
Industry payments across GA — which companies pay providers there.
